Jessica Burris, MD
she/her/hers
Assistant ProfessorDownloadHi-Res Photo
Cards
Appointments
Psychiatry
Primary
About
Copy Link
Titles
Assistant Professor
Biography
Board-certified psychiatrist with steadfast passion for both compassion and clinical excellence in patient-centered care and medical education.
Clinical areas of focus include emergency psychiatry, interventional psychiatry (ECT), and consult-liaison psychiatry.
Last Updated on March 10, 2026.
Appointments
Education & Training
- Resident
- Yale University (2023)
- MD
- Vanderbilt University School of Medicine (2019)
- BA
- University of Virginia
Board Certifications
Adult Psychiatry
- Certification Organization
- American Board of Psychiatry & Neurology
- Original Certification Date
- 2024
Research
Copy Link
Research at a Glance
Publications Timeline
A big-picture view of Jessica Burris's research output by year.
8Publications
116Citations
Publications
2024
Updated Developments in Fentanyl Use among Psychiatric Emergency Room Patients
Burris J, Fuehrlein B (2024) Updated Developments in Fentanyl Use among Psychiatric Emergency Room Patients. Emerg Med Inves 9: 10133. https://doi.org/10.29011/2475-5605.110133Peer-Reviewed Original Research
2023
Corticosteroids but not Anti-TNF Are Associated With Increased COVID-19 Complications in Patients With Inflammatory Bowel Disease
Long M, Parlett L, Lewis J, Haynes K, Adimadhyam S, Hou L, Wolfe A, Toh S, Burris J, Dorand J, Kappelman M. Corticosteroids but not Anti-TNF Are Associated With Increased COVID-19 Complications in Patients With Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2023, 30: 1345-1352. PMID: 37611117, DOI: 10.1093/ibd/izad176.Peer-Reviewed Original ResearchCitationsAltmetricReal-world Evidence Comparing Tofacitinib and Vedolizumab in Anti-TNF-experienced Patients With Ulcerative Colitis
Adimadhyam S, Lewis J, Simon A, Wolfe A, Smith S, Hou L, Moyneur É, Reynolds J, Toh S, Dobes A, Parlett L, Haynes K, Burris J, Dorand J, Long M, Kappelman M. Real-world Evidence Comparing Tofacitinib and Vedolizumab in Anti-TNF-experienced Patients With Ulcerative Colitis. Inflammatory Bowel Diseases 2023, 30: 554-562. PMID: 37358904, DOI: 10.1093/ibd/izad115.Peer-Reviewed Original ResearchCitationsAltmetricComparing Patient-Reported Outcomes Among Anti-TNF Experienced Patients With Ulcerative Colitis Initiating Vedolizumab Versus Tofacitinib
Kappelman M, Long M, Zhang X, Lin F, Weisbein L, Chen W, Burris J, Dorand J, Parlett L, Fehlmann T, Brensinger C, Haynes K, Nair V, Kaul A, Dobes A, Lewis J. Comparing Patient-Reported Outcomes Among Anti-TNF Experienced Patients With Ulcerative Colitis Initiating Vedolizumab Versus Tofacitinib. Crohn's & Colitis 360 2023, 5: otad031. PMID: 37350775, PMCID: PMC10284045, DOI: 10.1093/crocol/otad031.Peer-Reviewed Original ResearchCitationsAltmetricComparing Patient-Reported Outcomes Among Anti-TNF-Experienced Patients with Crohn’s Disease Initiating Vedolizumab Versus Ustekinumab
Kappelman M, Lewis J, Zhang X, Lin F, Weisbein L, Chen W, Burris J, Dorand J, Parlett L, Haynes K, Nair V, Kaul A, Dobes A, Long M. Comparing Patient-Reported Outcomes Among Anti-TNF-Experienced Patients with Crohn’s Disease Initiating Vedolizumab Versus Ustekinumab. Digestive Diseases And Sciences 2023, 68: 3413-3420. PMID: 37115362, DOI: 10.1007/s10620-023-07942-0.Peer-Reviewed Original ResearchCitationsAltmetric
2022
Real-World Evidence Comparing Vedolizumab and Ustekinumab in Antitumor Necrosis Factor-Experienced Patients With Crohn's Disease
Kappelman M, Adimadhyam S, Hou L, Wolfe A, Smith S, Simon A, Moyneur É, Reynolds J, Toh S, Dobes A, Parlett L, Haynes K, Selvan M, Ma Q, Nair V, Burris J, Dorand J, Dawwas G, Lewis J, Long M. Real-World Evidence Comparing Vedolizumab and Ustekinumab in Antitumor Necrosis Factor-Experienced Patients With Crohn's Disease. The American Journal Of Gastroenterology 2022, 118: 674-684. PMID: 36508681, DOI: 10.14309/ajg.0000000000002068.Peer-Reviewed Original ResearchCitationsAltmetric
2018
Crohn’s and Colitis Foundation of America Partners Patient-Powered Research Network
Chung AE, Vu MB, Myers K, Burris J, Kappelman MD. Crohn’s and Colitis Foundation of America Partners Patient-Powered Research Network. Medical Care 2018, 56: s33-s40. PMID: 30074949, PMCID: PMC6143211, DOI: 10.1097/mlr.0000000000000771.Peer-Reviewed Original ResearchCitationsAltmetric
2016
Harnessing person-generated health data to accelerate patient-centered outcomes research: the Crohn’s and Colitis Foundation of America PCORnet Patient Powered Research Network (CCFA Partners)
Chung AE, Sandler RS, Long MD, Ahrens S, Burris JL, Martin CF, Anton K, Robb A, Caruso TP, Jaeger EL, Chen W, Clark M, Myers K, Dobes A, Kappelman MD. Harnessing person-generated health data to accelerate patient-centered outcomes research: the Crohn’s and Colitis Foundation of America PCORnet Patient Powered Research Network (CCFA Partners). Journal Of The American Medical Informatics Association 2016, 23: 485-490. PMID: 26911821, PMCID: PMC4901381, DOI: 10.1093/jamia/ocv191.Peer-Reviewed Original ResearchCitationsAltmetric
Academic Achievements & Community Involvement
Copy Link
Featured
honor Yale Psychiatry Resident Teaching Award
06/15/2023Yale School of Medicine AwardYale University School of MedicineDetailsUnited Stateshonor Founder's Medal
05/10/2019Other AwardVanderbilt UniversityDetailsUnited Stateshonor Kaufman Prize in Medicine
05/10/2019Other AwardVanderbilt University School of MedicineDetailsUnited Stateshonor American Medical Women’s Association Glasgow-Rubin Citation for Academic Achievement
05/10/2019Other AwardAmerican Medical Women's AssociationDetailsUnited Stateshonor Beauchamp Prize in Psychiatry
05/09/2019Other AwardVanderbilt University Medical CenterDetailsUnited States
Honors
honor VA Connecticut Healthcare System Kindness Award
04/27/2023Hospital System AwardVA Connecticut Healthcare SystemDetailsUnited Stateshonor IBD Partners Top Citizen Scientist Award
12/03/2018National AwardPatient-Centered Research Outcomes InstituteDetailsUnited States